PRTG

Portage Biotech (PRTG)

‌

About Portage Biotech (PRTG)

Portage Biotech, Inc. is a biotechnology company, which engages in the research and development of immuno-oncology therapies for patients with cancer. Its portfolio includes first-in-class invariant natural killer T cell (iNKT) small molecule engagers and best-in-class adenosine antagonists. The company was founded by Gregory H. Bailey and James Mellon in 1973 and is headquartered in Road Town, British Virgin Islands.

Details

Daily high

$4.43

Daily low

$4.03

Price at open

$4.09

52 Week High

$23.01

52 Week Low

$2.10

Market cap

2.7M

Dividend yield

0.00%

Volume

25,188

Avg. volume

19,869

P/E ratio

-.06

Portage Biotech News